Delivery Order SPE2DB22D6029-SPE2DB24FT9WB
- Not listed
- This federal contract award is for the delivery of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price of $4,338.75 and has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the provision of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) by prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The firm fixed price delivery order has a potential value of $7,315.70 and a performance period through March 4, 2024. The contract does not utilize any set-aside designations. Amerisourcebergen Drug Corp is an experienced government contractor, holding an indefinite delivery contract...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,274.24 and runs through March 1, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packs to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $3,412.01 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
- This federal contract award, valued at $6,699.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of 4,564,128,973 units of Ondansetron ODT 8 mg Tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, is the prime contractor on an indefinite delivery...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets (30s) to the Defense Logistics Agency (DLA). The $11,596.90 firm-fixed-price delivery order was awarded to the prime contractor, AmerisourceBergen Drug Corp, on June 4, 2024, with a completion date of June 5, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The $7,081.25 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is for the provision of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The firm fixed price delivery order has a potential value of $2,668.06 and a completion date of February 15, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a completion date of December 9, 2024. The contract has a ceiling value of $8,884.29 and is a firm fixed-price delivery order. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp has a...
- This federal contract award is for the procurement of Ondansetron ODT 8 mg tablets by the Defense Logistics Agency (DLA) from prime contractor AmerisourceBergen Drug Corp. The $3,896.70 firm fixed-price delivery order has a completion date of December 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA to supply a comprehensive range of medical commodities to support military healthcare...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FT9WBDelivery Order
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $7,497.72 and a completion date of February 2, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 2/1/24 |